Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT01816256
Eligibility Criteria:
Inclusion Criteria:
* One of the three classical Philadelphia negative myeloproliferative neoplasms (polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF)) diagnosed according to WHO or International working group-Myelofibrosis research and treatment (IWG-MRT) criteria
* Palpable spleen length greater than 5 cm below the costal margin in MF (including primary MF or post-polycythemia vera MF (PPV-MF) post-polycythemia vera ET (PPV-ET)) or palpable spleen of any size in patients with PV or ET.
* Ability to understand and willing to sign a written consent form.
* Age 18 years or older at time of consent.
Exclusion criteria:
* Known history of portal vein thrombosis
* Known history of Budd-chairi syndrome
* Known history of oesophageal varices
* Known history of cirrhosis from any cause
* Known history of active bleeding
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01816256
Study Brief:
Protocol Section:
NCT01816256